183 related articles for article (PubMed ID: 17712791)
1. Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.
Ennishi D; Terui Y; Yokoyama M; Mishima Y; Takahashi S; Takeuchi K; Okamoto H; Tanimoto M; Hatake K
Am J Hematol; 2008 Jan; 83(1):59-62. PubMed ID: 17712791
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
[TBL] [Abstract][Full Text] [Related]
3. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
6. HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Marignani M; Mangone M; Cox MC; Angeletti S; Veggia B; Ferrari A; di Fonzo M; Begini P; Gigante E; Laverde G; Aloe-Spiriti A; Monarca B; Delle Fave G
Dig Liver Dis; 2011 Feb; 43(2):139-42. PubMed ID: 20554488
[TBL] [Abstract][Full Text] [Related]
7. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.
Dizdar O; Tapan U; Aksoy S; Harputluoglu H; Kilickap S; Barista I
Eur J Haematol; 2008 May; 80(5):381-5. PubMed ID: 18221389
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.
Nakai S; Masaki T; Shintani T; Deguchi A; Kimura Y; Himoto T; Kurokohchi K; Watanabe S; Kuriyama S
Oncol Rep; 2005 Jun; 13(6):1065-8. PubMed ID: 15870922
[TBL] [Abstract][Full Text] [Related]
9. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis.
Takao T; Kobayashi Y; Kuroda J; Omoto A; Nishimura T; Kamitsuji Y; Fukiya E; Nakamura C; Kimura S; Yoshikawa T
Am J Hematol; 2004 Dec; 77(4):419-20. PubMed ID: 15551361
[No Abstract] [Full Text] [Related]
10. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
11. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.
De Vita S; De Re V; Sansonno D; Sorrentino D; Corte RL; Pivetta B; Gasparotto D; Racanelli V; Marzotto A; Labombarda A; Gloghini A; Ferraccioli G; Monteverde A; Carbone A; Dammacco F; Boiocchi M
Hepatology; 2000 Jan; 31(1):182-9. PubMed ID: 10613744
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma].
Gasztonyi B; Pár A; Szomor A; Nagy A; Kereskai L; Losonczy H; Pajor L; Horanyi M; Mózsik G
Orv Hetil; 2000 Dec; 141(49):2649-51. PubMed ID: 11138474
[TBL] [Abstract][Full Text] [Related]
13. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
14. [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma].
Uzuka Y; Saitou Y; Saitou K; Suzuki S; Yamaguchi M
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1085-90. PubMed ID: 17637545
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease.
Musolino C; Campo S; Pollicino T; Squadrito G; Spatari G; Raimondo G
Haematologica; 1996; 81(2):162-4. PubMed ID: 8641648
[TBL] [Abstract][Full Text] [Related]
16. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients.
Bronowicki JP; Bineau C; Feugier P; Hermine O; Brousse N; Oberti F; Rousselet MC; Dharancy S; Gaulard P; Flejou JF; Cazals-Hatem D; Labouyrie E
Hepatology; 2003 Apr; 37(4):781-7. PubMed ID: 12668970
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.
Aksoy S; Abali H; Kilickap S; Erman M; Kars A
Clin Lab Haematol; 2006 Jun; 28(3):211-4. PubMed ID: 16706940
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy.
Coppola N; Pisaturo M; Guastafierro S; Tonziello G; Sica A; Iodice V; Sagnelli C; Ferrara MG; Sagnelli E
Dig Liver Dis; 2012 Jan; 44(1):49-54. PubMed ID: 21885355
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
